Stifel Financial’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.4M | Sell |
69,984
-10,026
| -13% | -$698K | ﹤0.01% | 1417 |
|
|
2025
Q4 | $5.31M | Sell |
80,010
-54,424
| -40% | -$3.52M | ﹤0.01% | 1292 |
|
|
2025
Q3 | $9.05M | Buy |
134,434
+23,072
| +21% | +$1.83M | 0.01% | 997 |
|
|
2025
Q2 | $9.72M | Buy |
111,362
+5,729
| +5% | +$449K | 0.01% | 895 |
|
|
2025
Q1 | $7.21M | Buy |
105,633
+4,620
| +5% | +$377K | 0.01% | 999 |
|
|
2024
Q4 | $7.86M | Buy |
101,013
+8,142
| +9% | +$603K | 0.01% | 967 |
|
|
2024
Q3 | $6.23M | Sell |
92,871
-24,859
| -21% | -$2.04M | 0.01% | 1080 |
|
|
2024
Q2 | $13.3M | Buy |
117,730
+32,593
| +38% | +$4.12M | 0.02% | 706 |
|
|
2024
Q1 | $11.8M | Buy |
85,137
+12,263
| +17% | +$1.54M | 0.01% | 748 |
|
|
2023
Q4 | $9.04M | Sell |
72,874
-116,582
| -62% | -$11.9M | 0.01% | 812 |
|
|
2023
Q3 | $17.7M | Sell |
189,456
-146,674
| -44% | -$16.5M | 0.02% | 511 |
|
|
2023
Q2 | $43.2M | Sell |
336,130
-25,186
| -7% | -$3.05M | 0.06% | 285 |
|
|
2023
Q1 | $42M | Sell |
361,316
-46,463
| -11% | -$5.2M | 0.06% | 288 |
|
|
2022
Q4 | $46.2M | Buy |
407,779
+21,026
| +5% | +$2.31M | 0.07% | 262 |
|
|
2022
Q3 | $31.1M | Sell |
386,753
-8,908
| -2% | -$754K | 0.05% | 315 |
|
|
2022
Q2 | $29.5M | Sell |
395,661
-53,211
| -12% | -$4.86M | 0.05% | 341 |
|
|
2022
Q1 | $57.4M | Buy |
448,872
+23,580
| +6% | +$2.58M | 0.08% | 238 |
|
|
2021
Q4 | $57.1M | Sell |
425,292
-8,396
| -2% | -$1.21M | 0.08% | 235 |
|
|
2021
Q3 | $59.3M | Buy |
433,688
+4,680
| +1% | +$590K | 0.09% | 222 |
|
|
2021
Q2 | $45.8M | Buy |
429,008
+108,416
| +34% | +$10.4M | 0.07% | 258 |
|
|
2021
Q1 | $28.8M | Buy |
320,592
+47,892
| +18% | +$4.5M | 0.05% | 329 |
|
|
2020
Q4 | $25.2M | Buy |
272,700
+2,356
| +0.9% | +$210K | 0.05% | 344 |
|
|
2020
Q3 | $27.9M | Buy |
270,344
+21,760
| +9% | +$2.27M | 0.06% | 288 |
|
|
2020
Q2 | $25.2M | Buy |
248,584
+2,836
| +1% | +$254K | 0.06% | 280 |
|
|
2020
Q1 | $16.5M | Buy |
245,748
+84,160
| +52% | +$5.24M | 0.05% | 321 |
|
|
2019
Q4 | $8.84M | Buy |
161,588
+125,200
| +344% | +$5.94M | 0.02% | 656 |
|
|
2019
Q3 | $1.36M | Sell |
36,388
-9,728
| -21% | -$378K | ﹤0.01% | 1563 |
|
|
2019
Q2 | $1.73M | Buy |
46,116
+1,936
| +4% | +$60.9K | ﹤0.01% | 1450 |
|
|
2019
Q1 | $1.32M | Buy |
44,180
+29,724
| +206% | +$1.04M | ﹤0.01% | 1485 |
|
|
2018
Q4 | $435K | Buy |
14,456
+6,768
| +88% | +$215K | ﹤0.01% | 2011 |
|
|
2018
Q3 | $275K | Buy |
+7,688
| New | +$238K | ﹤0.01% | 2407 |
|
|
2017
Q4 | – | Sell |
-34,268
| Closed | -$422K | – | 2670 |
|
|
2017
Q3 | $422K | Buy |
34,268
+4,516
| +15% | +$79.8K | ﹤0.01% | 1985 |
|
|
2017
Q2 | $539K | Sell |
29,752
-5,724
| -16% | -$106K | ﹤0.01% | 1823 |
|
|
2017
Q1 | $754K | Sell |
35,476
-28,940
| -45% | -$565K | ﹤0.01% | 1595 |
|
|
2016
Q4 | $963K | Sell |
64,416
-6,148
| -9% | -$109K | ﹤0.01% | 1413 |
|
|
2016
Q3 | $1.55M | Sell |
70,564
-10,696
| -13% | -$238K | 0.01% | 1111 |
|
|
2016
Q2 | $1.61M | Buy |
81,260
+11,620
| +17% | +$198K | 0.01% | 1101 |
|
|
2016
Q1 | $1.18M | Sell |
69,640
-23,576
| -25% | -$394K | 0.01% | 1156 |
|
|
2015
Q4 | $1.91M | Buy |
93,216
+15,168
| +19% | +$316K | 0.01% | 985 |
|
|
2015
Q3 | $1.68M | Sell |
78,048
-175,368
| -69% | -$3.91M | 0.01% | 999 |
|
|
2015
Q2 | $5.05M | Sell |
253,416
-626,416
| -71% | -$11M | 0.03% | 569 |
|
|
2015
Q1 | $13.7M | Sell |
879,832
-157,080
| -15% | -$2.37M | 0.08% | 309 |
|
|
2014
Q4 | $20.6M | Sell |
1,036,912
-164,256
| -14% | -$2.01M | 0.11% | 223 |
|
|
2014
Q3 | $12M | Sell |
1,201,168
-237,160
| -16% | -$2.42M | 0.11% | 246 |
|
|
2014
Q2 | $14.3M | Buy |
1,438,328
+261,572
| +22% | +$2.32M | 0.13% | 207 |
|
|
2014
Q1 | $12.2M | Buy |
+1,176,756
| New | +$12.2M | 0.12% | 237 |
|
Other funds holding DXCM
VCM
VPM
Stifel Financial's DXCM Position: Q1 2026 in Review
Stifel Financial reduced its DexCom (DXCM) stake by 13% in Q1 2026, selling an estimated $698K and leaving 69,984 shares worth $4.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1417.
Stifel Financial first reported a position in DXCM in Q1 2014 and has held it in 46 quarters since. The position peaked at $59.3M in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Stifel Financial held 69,984 shares of DexCom worth $4.4M as of Q1 2026.
- Stifel Financial sold 10,026 DexCom shares in Q1 2026, an estimated $698K.
- DexCom made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #1417 holding.
- Stifel Financial first reported a position in DexCom in Q1 2014 and has held it in 46 quarters since.
- Stifel Financial's DexCom position peaked at $59.3M in Q3 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.